Sanofi-aventis Avapro Product Recall(2021-06-14)
Sanofi-Aventis Avapro Recall Summary Sanofi-Aventis is recalling Avapro (irbesartan), a blood pressure medication, across Canada due to product safety concerns. This is a Class I recall, which means the product could cause serious health problems or death. The recall affects all Avapro products distributed in Canada.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2021-06-14
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/25540d06-acfd-42e5-9f13-1a0e2438af1d